Page 59 - Read Online
P. 59

Malherbe et al. Rare Dis Orphan Drugs J 2024;3:7  https://dx.doi.org/10.20517/rdodj.2023.49  Page 9 of 11

               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2024.


               REFERENCES
               1.       World Health Organization. Management of birth defects and haemoglobin disorders. Report of a joint who-march of dimes meeting.
                   Geneva, Switzerland, 17-19 May 2006. Available from: https://iris.who.int/bitstream/handle/10665/43587/9789241594929_eng.
                   pdf?sequence=1 [Last accessed on 27 Feb 2024].
               2.       Malherbe HL, Modell B, Blencowe H, Strong KL, Aldous C. A review of key terminology and definitions used for birth defects
                   globally. J Community Genet 2023;14:241-62.  DOI  PubMed  PMC
               3.       El-Hattab AW, Almannai M, Sutton VR. Newborn screening: history, current status, and future directions. Pediatr Clin N Am
                   2018;65:389-405.  DOI
               4.       Howson CP, Cedergren B, Giugliani R, et al. Universal newborn screening: a roadmap for action. Mol Genet Metab 2018;124:177-83.
                   DOI
               5.       Maccready RA, Hussey MG. Newborn phenylketonuria detection program in massachusetts. Am J Public Health Nations Health
                   1964;54:2075-81.  DOI  PubMed  PMC
               6.       Levy HL. Robert guthrie and the trials and tribulations of newborn screening. Int J Neonatal Screen 2021;7:5.  DOI  PubMed  PMC
               7.       Caggana M, Jones EA, Shahied SI, Tanksley S, Hermerath CA, Lubin IM. Newborn screening: from guthrie to whole genome
                   sequencing. Public Health Rep 2013;128:14-9.  DOI  PubMed  PMC
               8.       Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics
                   1963;32:338-43.  DOI  PubMed
               9.       Parker SP, Cubitt WD. The use of the dried blood spot sample in epidemiological studies. J Clin Pathol 1999;52:633-9.  DOI  PubMed
                   PMC
               10.      Population screening by guthrie test for phenylketonuria in South-East Scotland. Report by the consultant paediatricians and medical
                   officers of health of the S.E. Scotland hospital region. Br Med J 1968;1:674-6.  DOI  PubMed  PMC
               11.      Dussault JH, Coulombe P, Laberge C, Letarte J, Guyda H, Khoury K. Preliminary report on a mass screening program for neonatal
                   hypothyroidism. J Pediatr 1975;86:670-4.  DOI  PubMed
               12.      Pang S, Hotchkiss J, Drash AL, Levine LS, New MI. Microfilter paper method for 17α-hydroxyprogesterone radioimmunoassay: its
                   application for rapid screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 1977;45:1003-8.  DOI
               13.      Crossley JR, Elliott RB, Smith PA. Dried-blood spot screening for cystic fibrosis in the newborn. Lancet 1979;1:472-4.  DOI  PubMed
               14.      Chace DH, Millington DS, Terada N, Kahler SG, Roe CR, Hofman LF. Rapid diagnosis of phenylketonuria by quantitative analysis
                   for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry. Clin Chem 1993;39:66-71.  DOI
               15.      Rashed MS, Ozand PT, Bucknall MP, Little D. Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino
                   acids profiling using automated electrospray tandem mass spectrometry. Pediatr Res 1995;38:324-31.  DOI  PubMed
               16.      Millington DS, Kodo N, Norwood DL, Roe CR. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential
                   for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis 1990;13:321-4.  DOI  PubMed
               17.      Ellinwood NM. Newborn screening and the recommended uniform screening panel: optimal submissions and suggested improvements
                   based on an advocacy organization’s decade-long experience. Am J Med Genet C Semin Med Genet 2022;190:156-61.  DOI
               18.      Therrell BL, Padilla CD, Loeber JG, et al. Current status of newborn screening worldwide: 2015. Semin Perinatol 2015;39:171-87.
                   DOI
               19.      Advisory Committee on Heritable Disorders in Newborns and Children. Recommended uniform screening panel. 2018. Available
                   from: https://www.hrsa.gov/advisory-committees/heritable-disorders/rusp [Last accessed on 27 Feb 2024].
               20.      Padilla CD, de la Paz EM. Genetic services and testing in the Philippines. J Community Genet 2013;4:399-411.  DOI  PubMed  PMC
               21.      Sustainable Development Goal. Goal 3: ensure healthy lives and promote wellbeing for all and at all ages. Available from: http://www.
                   un.org/sustainabledevelopment/health/ [Last accessed on 27 Feb 2024].
               22.      Stats Sa. Statistical release P0302. Mid-year population estimates 2022. Available from: http://www.statssa.gov.za/publications/P0302/
                   P03022022.pdf [Last accessed on 27 Feb 2024].
               23.      Stats Sa. Statistical release P0305. Recorded live births 2021. Available from: http://www.statssa.gov.za/publications/P0305/
   54   55   56   57   58   59   60   61   62   63   64